Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Golden Arrow Merger (GAMC) Competitors

Golden Arrow Merger logo

GAMC vs. EVGN, GURE, NITO, DNMR, SNES, HGAS, CNEY, TANH, GAMCW, and LNZAW

Should you be buying Golden Arrow Merger stock or one of its competitors? The main competitors of Golden Arrow Merger include Evogene (EVGN), Gulf Resources (GURE), N2OFF (NITO), Danimer Scientific (DNMR), SenesTech (SNES), Global Gas (HGAS), CN Energy Group. (CNEY), Tantech (TANH), Golden Arrow Merger (GAMCW), and LanzaTech Global (LNZAW). These companies are all part of the "chemicals" industry.

Golden Arrow Merger vs.

Evogene (NASDAQ:EVGN) and Golden Arrow Merger (NASDAQ:GAMC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership, profitability and earnings.

Golden Arrow Merger has lower revenue, but higher earnings than Evogene.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evogene$8.51M0.87-$23.88M-$3.11-0.44
Golden Arrow MergerN/AN/A-$1.47MN/AN/A

Evogene received 221 more outperform votes than Golden Arrow Merger when rated by MarketBeat users.

CompanyUnderperformOutperform
EvogeneOutperform Votes
221
54.17%
Underperform Votes
187
45.83%
Golden Arrow MergerN/AN/A

In the previous week, Evogene had 6 more articles in the media than Golden Arrow Merger. MarketBeat recorded 6 mentions for Evogene and 0 mentions for Golden Arrow Merger. Evogene's average media sentiment score of 0.48 beat Golden Arrow Merger's score of -0.57 indicating that Evogene is being referred to more favorably in the media.

Company Overall Sentiment
Evogene Neutral
Golden Arrow Merger Negative

Evogene has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Golden Arrow Merger has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500.

Evogene currently has a consensus target price of $12.00, suggesting a potential upside of 769.57%. Given Evogene's stronger consensus rating and higher possible upside, research analysts plainly believe Evogene is more favorable than Golden Arrow Merger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evogene
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Golden Arrow Merger
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Golden Arrow Merger has a net margin of 0.00% compared to Evogene's net margin of -314.43%. Golden Arrow Merger's return on equity of 0.00% beat Evogene's return on equity.

Company Net Margins Return on Equity Return on Assets
Evogene-314.43% -109.05% -52.55%
Golden Arrow Merger N/A N/A -24.61%

10.4% of Evogene shares are held by institutional investors. Comparatively, 5.5% of Golden Arrow Merger shares are held by institutional investors. 7.4% of Evogene shares are held by insiders. Comparatively, 77.4% of Golden Arrow Merger shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Evogene beats Golden Arrow Merger on 9 of the 14 factors compared between the two stocks.

Remove Ads
Get Golden Arrow Merger News Delivered to You Automatically

Sign up to receive the latest news and ratings for GAMC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GAMC vs. The Competition

MetricGolden Arrow MergerIndustrial organic chemicals IndustryMaterials SectorNASDAQ Exchange
Market Cap$2.58M$2.38B$3.09B$7.93B
Dividend YieldN/A3.63%5.16%4.05%
P/E RatioN/A16.6597.8518.73
Price / SalesN/A27.9825,633,028,482,576,500.00119.11
Price / CashN/A23.6224.3634.64
Price / Book-0.131.404.884.19
Net Income-$1.47M-$13.51M$154.02M$247.07M

Golden Arrow Merger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GAMC
Golden Arrow Merger
N/A$0.33
+0.5%
N/A-96.9%$2.58MN/A0.001Gap Up
High Trading Volume
EVGN
Evogene
1.9743 of 5 stars
$1.40
-0.4%
$12.00
+757.1%
-82.8%$7.51M$8.51M-0.31140Earnings Report
Analyst Forecast
Short Interest ↑
GURE
Gulf Resources
0.4451 of 5 stars
$0.70
-4.8%
N/A-45.7%$7.46M$12.80M-0.07420Short Interest ↑
Positive News
Gap Down
NITO
N2OFF
1.8123 of 5 stars
$0.29
-4.0%
N/AN/A$4.45M$175,308.000.002Short Interest ↓
Gap Down
DNMR
Danimer Scientific
1.1097 of 5 stars
$1.17
-5.4%
$13.83
+1,079.8%
-97.6%$3.54M$37.43M-0.03280
SNES
SenesTech
2.2127 of 5 stars
$2.30
-3.4%
$10.00
+334.8%
-72.4%$2.38M$1.65M0.0030Earnings Report
Short Interest ↑
News Coverage
High Trading Volume
HGAS
Global Gas
N/A$0.16
-44.8%
N/A-92.7%$1.30MN/A0.002
CNEY
CN Energy Group.
0.3492 of 5 stars
$0.18
+4.4%
N/A-85.2%$1.27M$50.96M0.00160Short Interest ↑
Gap Down
TANH
Tantech
0.2616 of 5 stars
$2.94
+2.4%
N/A-89.0%$279,000.00$49.10M0.0070Short Interest ↑
Positive News
Gap Up
GAMCW
Golden Arrow Merger
N/A$0.04
flat
N/AN/A$0.00N/A0.0012
LNZAW
LanzaTech Global
N/A$0.13
-3.7%
N/A-40.9%$0.00$58.03M0.003Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:GAMC) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners